Biotie Therapies Corp

Biotie Therapies Corp. announces change in the number of votes relating to its shares

TURKU, 16-3-2015 — /EuropaWire/ — Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares held as treasury shares,…

9 years ago

Biotie Therapies Corp: Clinical study with Biotie’s BTT1023 in primary sclerosing cholangitis awarded external grant funding

Turku, Finland, 25-7-2014 — /EuropaWire/ — Biotie Therapies Corp. will be working in partnership with the University of Birmingham, UK, who have…

10 years ago

Biotie Therapies Corp. released its H1-2013 interim report

19-8-2013 — /EuropaWire/ — Company Highlights April - June 2013 Biotie obtained an exclusive option to acquire Neurelis, Inc., a private specialty…

11 years ago

Biotie Therapies Corp. through its partner H.Lundbeck A/S introduced Selincro in the United Kingdom

Turku, 30-5-2013 — /europawire.eu/ — Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has launched Selincro in the United Kingdom.…

11 years ago